0001495800-19-000002.txt : 20190802 0001495800-19-000002.hdr.sgml : 20190802 20190802164419 ACCESSION NUMBER: 0001495800-19-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190801 FILED AS OF DATE: 20190802 DATE AS OF CHANGE: 20190802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: King Gary A. CENTRAL INDEX KEY: 0001495800 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 19996554 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: 801-584-3600 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2019-08-01 0 0000899923 MYRIAD GENETICS INC MYGN 0001495800 King Gary A. 320 WAKARA WAY SALT LAKE CITY UT 84108 0 1 0 0 Exec. VP International Ops Common Stock 2019-08-01 4 M 0 30000 26.49 A 164871 D Common Stock 2019-08-01 4 S 0 30000 46.1901 D 134871 D Common Stock 2019-08-01 4 M 0 10000 23.98 A 144871 D Common Stock 2019-08-01 4 S 0 10000 43.4816 D 134871 D Common Stock 2019-08-01 4 M 0 20000 19.47 A 154871 D Common Stock 2019-08-01 4 S 0 20000 39.4405 D 134871 D Non-Qualified Stock Option (right to buy) 19.47 2019-08-01 4 M 0 20000 0.0 D 2021-09-13 Common Stock 20000 7432 D Non-Qualified Stock Option (right to buy) 23.98 2019-08-01 4 M 0 10000 0.0 D 2022-03-07 Common Stock 10000 1830 D Non-Qualified Stock Option (right to buy) 26.49 2019-08-01 4 M 0 30000 0.0 D 2021-09-17 Common Stock 30000 106225 D This transaction was effected pursuant to a Rule 10b5-1 trading plan. The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations. By: Nathan Smith For: Gary A. King 2019-08-02 EX-24 2 powerofattorneyking.txt EDGAR SUPPORTING DOCUMENT POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Benjamin Jackson, R. Bryan Riggsbee, Nathan A. Smith and Ben Wheeler of Myriad Genetics, Inc. the Company, and Jonathan L. Kravetz, Daniel Follansbee, Page Hubben and Anne Leland of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., signing singly, with full power of substitution, the undersigned s true and lawful attorney-in-fact to: 1 execute for and on behalf of the undersigned, in the undersigned s capacity as an officer, director and/or 10% shareholder of the Company, forms and authentication documents for EDGAR Filing Access; 2 do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such forms and authentication documents; 3 execute for and on behalf of the undersigned, in the undersigned s capacity as an officer, director and/or 10% shareholder of the Company, Forms 3, 4 and 5 in accordance with Section 16a of the Securities Exchange Act of 1934, as amended, and the rules thereunder; 4 do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and 5 take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interests of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact, on behalf of the undersigned pursuant to this Power of Attorney, shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact s discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-facts substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed this 18 day of June 2019. /s/ Gary A. King Gary A. King